This is an English translation of a Hebrew immediate report that was published on March 13, 2022 (Ref No.: 2022-01-028975) (hereafter: the “Hebrew Version“). This English version is only for convenience purposes. This is not an official translation and has no binding force. Whilst reasonable care and skill have been exercised in the preparation hereof, no translation can ever perfectly reflect the Hebrew Version. In the event of any discrepancy between the Hebrew Version and this translation, the Hebrew Version shall prevail.
(the “Company“)
March 14, 2022
Israel Securities Authority
Tel Aviv Stock Exchange Ltd .
Dear Sirs and Madams,
Re: Beeio Honey Technologies Ltd. (Subsidiary) has Filed a Patent Application for Methods for
the Production of Cultured Low Glycemic Index Honey
The Company is honored to update that further to its immediate report as of August 12, 2021 (Ref No. 2021-01-064468), in which the Company notified its shareholders that it has started researching the production of cultivated honey from “stingless” bees, Beeio Honey Technologies Ltd., a wholly-owned subsidiary (the “Subsidiary“), has filed a provisional patent application (the “Patent Application“) in the USA for:
Methods and Systems for Producing Emulated Low Glycemic Index Honey
The purpose of the method described in the Patent Application is the development of a new, additional process in the Subsidiary for the production of cultured low glycemic index honey. The inspiration for this development comes from the rare honey naturally produced by “stingless” bees, concurrently with its existing developments and research channels involving the production of cultured honey similar in composition to the more common honey produced by stinging honeybees (Apis). Development of such process, to the extent that the Subsidiary succeeds in its development, will allow the Subsidiary to produce cultured honey with low glycemic index as a future product of the Company, which the Company believes may have substantial industrial value.
“Stingless” bee honey is an expensive honey that contains a rare type of sugar that is not found as a major ingredient in any other food, it has a lower glycemic index compared to regular
honey and is considered healthier.1,2 The glycemic index ranks foods according to their effect on blood sugar levels, so that food that breaks down quickly and sharply raises the blood sugar level gets a high value, and food that breaks down slowly and moderately raises the blood sugar level gets a low value. The glycemic index helps maintain a proper and balanced diet and is of particular importance for people with diabetes who need to maintain stable sugar levels and avoid sharp rises and falls.3,4 It is also of great value for people who want to watch their weight because foods with a high glycemic index are metabolized rapidly and the feeling of hunger quickly returns5.
The Company estimates that this technological development will involve the following advantages:
S, Sasaki S, Nakagawa H. Dietary glycemic index and risk of type 2 diabetes mellitus in middle-aged Japanese men. Metabolism. 2012;61:47-55.
The Company estimates that the acceptance of the requested Patent Application may provide to the Company and the Subsidiary further protection to its intellectual property, coupled with five other patent applications of the Subsidiary, of which three are provisional applications and have been filed in the USA and two are international patent applications (PCT). These and other applications, if such are filed by the Company and/or the Subsidiary, are part of the Company’s long-term strategic plan to produce a substantial technological advantage in its field by protecting its intellectual property.
The information mentioned in this notice is “Forward-Looking Statement” as defined in The Securities Law, 5728-1968, based on the information known to the Company as of this date, and on estimates and predictions which their realization depends, among others, on factors that are outside of the Company’s control. To be noted, the Company is a research and development company and as such, its estimations might be realized differently, if at all, given that the Company’s research is preliminary and precedential.
Beeio Honey Ltd. published this content on 14 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 March 2022 14:43:02 UTC.


Leave a Reply

Your email address will not be published. Required fields are marked *